Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „occurring“
Suchtreffer
Begriffe & Kennungen
Janumet · 4.8 · Among these patients, adverse events reported regardless of causal relationship to medicinal product occurring
Eintrag öffnenJavlor · 4.8 · Adverse reactions in all indications Adverse reactions occurring in patients with transitional cell carcinoma
Eintrag öffnenJuluca · 4.8 · Dolutegravir or rilpivirine have been associated with increases in serum creatinine occurring in the first wee
Eintrag öffnenKisplyx · 4.8 · The most frequently reported adverse reactions(occurring in ≥30% of patients) were diarrhoea (69.0%), fatigue
Eintrag öffnenKyprolis · 4.8 · 18 cyclical thrombocytopenia with platelet nadirs occurring on day 8 or 15 of each 28-day cycle and usually as
Eintrag öffnenLenvima · 4.8 · The most common (occurring in ≥5% of patients) severe (Grade ≥3) adverse reactions were hypertension (37.2%),
Eintrag öffnenLenvima · 4.8 · The most frequently reported adverse reactions (occurring in ≥30% of patients) are hypertension (44.0%), diarr
Eintrag öffnenLenvima · 4.8 · The most frequently reported adverse reactions (occurring in ≥30% of patients) are hypertension (68.6%), diarr
Eintrag öffnenLorviqua · 4.8 · Table 2 presents adverse reactions occurring in 547 adult patients treated with lorlatinib 100 mg once daily w
Eintrag öffnenLunsumio · 4.8 · CRS (ASTCT grading system) of any grade occurred in 26% (36/139) of patients, with grade 2 occurring in 7.2%,
Eintrag öffnenLunsumio · 4.8 · Table 6 Adverse reactions occurring in patients treated with Lunsumio
Eintrag öffnenLunsumio · 4.8 · Table 6 Adverse reactions occurring in patients treated with Lunsumio
Eintrag öffnenLynozyfic · 4.8 · Table 8: Adverse reactions occurring in patients with multiple myeloma treated with LYNOZYFIC
Eintrag öffnenLynparza · 4.8 · The Grade ≥3 adverse reactions occurring in > 2% of patients were anaemia (14%), neutropenia (5%), fatigue/ast
Eintrag öffnenMabThera · 4.8 · 24 Table 5 Adverse reactions occurring at 6-months in ≥ 5% of adult patients receiving MabThera in GPA/MPA Stu
Eintrag öffnenMabThera · 4.8 · Table 6 Adverse reactions occurring in ≥ 5% of adult patients receiving MabThera in GPA/MPA Study 2 (Rituximab
Eintrag öffnenMabThera · 4.8 · and adverse reactions occurring on the day of or one day after the infusion. The most common infusion-related
Eintrag öffnenMektovi · 4.8 · Table 3: Adverse reactions occurring in patients receiving binimetinib in combination with encorafenib at the
Eintrag öffnenMicardisPlus · 4.8 · Tabulated list of adverse reactions Adverse reactions reported in all clinical trials and occurring more frequ
Eintrag öffnenMicardisPlus · 4.8 · Tabulated list of adverse reactions Adverse reactions reported in all clinical trials and occurring more frequ
Eintrag öffnen